Filter
1698
Filtered Results: 1698
Text search:
adverse
reactions
Featured
Recommendations
202
New Publications
465
Language
Document type
No document type
1011
Guidelines
302
Studies & Reports
175
Manuals
103
Strategic & Response Plan
35
Fact sheets
34
Training Material
21
Situation Updates
6
Brochures
4
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
111
South Africa
50
Global
43
Ethiopia
39
Western and Central Europe
39
Nigeria
37
Kenya
37
Tanzania
30
Uganda
29
Nepal
28
Latin America and the Carribbean
25
Zambia
24
Malawi
22
Ghana
21
Sierra Leone
19
Philippines
18
Africa
17
Eastern Europe
17
Liberia
16
Bangladesh
16
Zimbabwe
13
Rwanda
13
Namibia
13
Cambodia
12
Myanmar / Burma
12
South–East Asia Region
12
Indonesia
10
Ukraine
9
Eswatini/ Swaziland
8
Botswana
8
Lesotho
8
Congo, Democratic Republic of
7
USA
7
Asia
6
Senegal
5
Syria
5
Colombia
5
East and Southern Africa
5
Middle East and North Africa
5
South Sudan
4
Germany
4
Brazil
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Haiti
3
Thailand
3
Mozambique
3
Argentina
3
Western Pacific Region
3
Moldova
3
Guinea
2
Cameroon
2
Afghanistan
2
Lebanon
2
Benin
2
Ecuador
2
Bolivia
2
Sri Lanka
2
Bhutan
2
Venezuela
2
Timor Leste/ East Timor
2
Russia
2
Burkina Faso
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Somalia
1
Pakistan
1
Iraq
1
Gambia
1
China
1
Ireland
1
Libya
1
Angola
1
Madagascar
1
Chile
1
Yemen
1
Other region
1
Paraguay
1
Fiji
1
Solomon Islands
1
Palestine
1
North Korea
1
Laos
1
Tajikistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Vietnam
1
North America
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
596
Clinical Guidelines
244
Public Health
82
Women & Child Health
63
Key Resources
50
Capacity Building
29
Pharmacy & Technologies
25
Toolboxes
TB
172
Mental Health
151
COVID-19
137
HIV
106
Pharmacy
88
NTDs
65
Rapid Response
51
AMR
43
Ebola
40
Planetary Health
39
Caregiver
36
Refugee
26
NCDs
26
Conflict
24
Specific Hazards
22
Polio
19
Zika
16
Disability
11
Cholera
10
Natural Hazards
10
Global Health Education
9
Health Financing Toolbox
3
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
Abstract-The paper precisely and briefly explains the socio-economic challenges of persons with disabilities with focus on Ethiopia. The findings of the paper also indicates that, across the countries persons with disabilities have poorer health accesses, lower education achievements,...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
This drill package is part of a broader COVID-19 simulation exercise package, including vaccine tabletop exercises(TTX). For exercises to be most effective, it is recommended they should be part of a comprehensive programme made up of progressively complex exercises, each exercise ...
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physicians who will provide care to older people in primar...
The Practical Approach to Care Kit (PACK) is a health systems improvement programme designed to support the work of primary care health workers in underserved communities (like doctors, nurses, midwives, health officers, community health practitioners), strengthen the health services in which they w...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon...
Revision Bulletin ESPNF
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
